HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazunori Kageyama Selected Research

Adrenocorticotropic Hormone (ACTH)

9/2022Effects of tubastatin A on adrenocorticotropic hormone synthesis and proliferation of AtT-20 corticotroph tumor cells.
2/2021Differential effects of β-arrestin1 and β-arrestin2 on somatostatin receptors in murine AtT-20 corticotroph tumor cells.
1/2021Involvement of histone deacetylase 1/2 in adrenocorticotropic hormone synthesis and proliferation of corticotroph tumor AtT-20 cells.
3/2020Presence of aberrant adrenocorticotropic hormone precursors in two cases of McCune-Albright syndrome.
2/2020Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation.
6/2019Lapatinib decreases the ACTH production and proliferation of corticotroph tumor cells.
1/2017Inhibitory effects of a selective Jak2 inhibitor on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT20 cells.
1/2017Acute mesenteric ischemia and hepatic infarction after treatment of ectopic Cushing's syndrome.
3/2016Association Between Pituitary-Adrenal Axis Dominance Over the Renin-Angiotensin-Aldosterone System and Hypertension.
1/2016The Evaluation of Adrenal Function in Two Cases of Hypocortisolism Accompanied by Liver Cirrhosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazunori Kageyama Research Topics

Disease

28Neoplasms (Cancer)
09/2022 - 02/2002
19Pituitary ACTH Hypersecretion
09/2022 - 12/2002
10Pituitary Neoplasms (Pituitary Adenoma)
09/2022 - 12/2002
9ACTH-Secreting Pituitary Adenoma
09/2022 - 01/2014
9Cushing Syndrome
09/2022 - 01/2009
5Hypertension (High Blood Pressure)
02/2022 - 06/2003
5Ectopic ACTH Syndrome
03/2020 - 01/2009
5Adenoma (Adenomas)
10/2018 - 02/2002
4Acromegaly
03/2020 - 12/2002
4Insulin Resistance
01/2020 - 01/2016
3Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2022 - 08/2007
3Hypopituitarism (Sheehan's Syndrome)
12/2019 - 08/2008
2Anorexia
11/2021 - 12/2008
2Hyperaldosteronism (Conn Syndrome)
01/2016 - 04/2015
2Melanoma (Melanoma, Malignant)
11/2014 - 05/2013
2Prolactinoma (Prolactinomas)
09/2014 - 02/2002
2Glucose Intolerance
05/2008 - 06/2003
2Hypoglycemia (Reactive Hypoglycemia)
08/2007 - 12/2003
1Sexual Infantilism
02/2022
1Hypokalemia
02/2022
1Amenorrhea
02/2022
1Polyostotic Fibrous Dysplasia (McCune Albright Syndrome)
03/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2019
1Hypothyroidism
12/2019
1Neoplasm Metastasis (Metastasis)
12/2019
1Hyperthyroidism
10/2018
1Adrenal Gland Neoplasms (Adrenal Cancer)
04/2018
1Thyrotoxicosis
01/2018
1Graves Disease (Basedow Disease)
01/2018
1Thyroid Diseases (Thyroid Disease)
01/2018
1Hepatic Infarction
01/2017
1Carcinoid Tumor (Carcinoid)
01/2017
1Type 2 Diabetes Mellitus (MODY)
01/2017
1Hyperprolactinemia
01/2017
1Thromboembolism
01/2017
1Venous Thromboembolism
01/2017
1Mesenteric Ischemia
01/2017
1Critical Illness (Critically Ill)
01/2016

Drug/Important Bio-Agent (IBA)

32Adrenocorticotropic Hormone (ACTH)FDA Link
09/2022 - 12/2002
13Hydrocortisone (Cortisol)FDA LinkGeneric
09/2022 - 12/2002
9Messenger RNA (mRNA)IBA
09/2022 - 01/2006
7Pro-Opiomelanocortin (Proopiomelanocortin)IBA
09/2022 - 09/2004
7Dexamethasone (Maxidex)FDA LinkGeneric
02/2021 - 12/2002
5Corticotropin-Releasing HormoneIBA
05/2013 - 11/2005
5Growth Hormone (Somatotropin)IBA
09/2012 - 02/2002
4growth hormone-releasing peptide-2 (KP 102)IBA
10/2018 - 08/2008
4Glucose (Dextrose)FDA LinkGeneric
12/2017 - 08/2005
4UrocortinsIBA
11/2017 - 11/2005
4AldosteroneIBA
03/2016 - 02/2004
4Proteins (Proteins, Gene)FDA Link
01/2015 - 01/2006
3Histone Deacetylases (Histone Deacetylase)IBA
09/2022 - 01/2015
3Histone Deacetylase InhibitorsIBA
09/2022 - 01/2015
3ProlactinIBA
01/2017 - 02/2002
3GlucocorticoidsIBA
01/2017 - 05/2008
3ReninIBA
03/2016 - 02/2004
3Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
06/2010 - 02/2004
3Peptides (Polypeptides)IBA
04/2009 - 09/2004
2Immune Checkpoint InhibitorsIBA
01/2022 - 07/2019
2CRF receptor type 2IBA
11/2021 - 11/2017
2CRF receptor type 1IBA
11/2021 - 06/2010
2pasireotideIBA
02/2021 - 08/2014
2trichostatin A (A 300)IBA
01/2021 - 01/2015
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
03/2020 - 08/2014
2Pharmaceutical PreparationsIBA
02/2020 - 08/2014
2Hormones (Hormone)IBA
10/2018 - 03/2016
2Octreotide (Sandostatin)FDA LinkGeneric
10/2018 - 08/2014
2SteroidsIBA
03/2016 - 01/2008
2Insulin (Novolin)FDA Link
01/2016 - 08/2008
2Monophenol Monooxygenase (Tyrosinase)IBA
11/2014 - 05/2013
2CabergolineFDA LinkGeneric
09/2014 - 02/2002
2somatocrinin receptorIBA
11/2009 - 08/2009
2Insulin-Like Growth Factor I (IGF-1)IBA
08/2005 - 02/2002
1tubastatin AIBA
09/2022
1Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA
02/2022
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
02/2021
1Somatostatin Receptors (Somatostatin Receptor)IBA
02/2021
1Histone Deacetylase 1IBA
01/2021
1romidepsin (FK228)FDA Link
01/2021
1EnzymesIBA
02/2020
1Ubiquitin-Specific ProteasesIBA
02/2020
1NormetanephrineIBA
01/2020
1pembrolizumabIBA
12/2019
1CorticosteroneIBA
06/2019
1ErbB Receptors (EGF Receptor)IBA
06/2019
1Deubiquitinating EnzymesIBA
06/2019
1Lapatinib (GW572016)FDA Link
06/2019
1Tyrosine Kinase InhibitorsIBA
06/2019
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
10/2018
1Pituitary HormonesIBA
10/2018
1Bromocriptine (Parlodel)FDA LinkGeneric
10/2018
1Thyroid HormonesIBA
01/2018
1GonadotropinsIBA
11/2017
1Small Interfering RNA (siRNA)IBA
01/2017
1SD 1029IBA
01/2017
1Blood Glucose (Blood Sugar)IBA
01/2016
1tanespimycin (17AAG)IBA
08/2015
1Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2015

Therapy/Procedure

8Therapeutics
03/2020 - 01/2008
2Aftercare (After-Treatment)
12/2019 - 01/2017
1Perioperative Period
01/2017